Vijay Hall

Bachelor of Medicine and Bachelor of Science,  The Johns Hopkins Hospital 

Location: India

Consulting Services

Data Science-Bioinformatics Research Consulting Pharma-CRO-Device

Areas Of Interest

Hydrillas Intraocular Injection Azotobacteraceae Ocular Dyskinesias, Paroxysmal p21 c-K-ras Tunicates Fibrous Histiocytoma Feasibility Study Traps, Extracellular DNA Of Heavens, Tree Inhibitors, Na-K-CL Symporter Valve Prolapse, Tricuspid Pott Puffy Tumor Hydroa Vacciniforme Cortex, Lateral Orbitofrontal Crib VIP Receptors, Type II Apexogenesis Passive Tremors Candimon Transplant, Organ Ischemia Reperfusion Injury Medicine, Mongolian Folk Three-Dimensional Images Intestinal L Cells Prokallikrein A, Plasma Aircraft Cost Shifting Amanta HCI AZU Dipalmitoyllecithin Ferroptosis Phosphoenolpyruvate Carboxykinase (ATP) Vagotomy Spices Ethidium Invertebrate

Professional Narrative

Dr. Vijay Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Amgen 1990
Senior Director, Harvard Med 2013

Education

Master of Science in physician assistant, Perelman School of Medicine 2013
Doctor of osteopathic medicine, Perelman School of Medicine 2007

Referees


Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :